Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s.
暂无分享,去创建一个
J. Crowe | S. Norris | S. Stewart | C. O’Farrelly | Ó. Crosbie | G. Courtney | P. Garvey | N. Nolan | J. Hegarty | N. Murphy | L. Thornton | John Lee | P. Flanagan | Michele Tait | A. Brennan | F. Murray | C. Mcnulty | Margaret McIver
[1] Douglas L. Nguyen,et al. Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies. , 2016, North American journal of medicine & science.
[2] G. Dusheiko,et al. Natural history of hepatitis C. , 2014, Journal of hepatology.
[3] T. Berg,et al. Evaluation of liver disease progression in the German hepatitis C virus (1b)‐contaminated anti‐D cohort at 35 years after infection , 2014, Hepatology.
[4] M. Zwahlen,et al. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study , 2009, Journal of viral hepatitis.
[5] L. Seeff. The history of the “natural history” of hepatitis C (1968–2009) , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[6] G. Alexander,et al. Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type? , 2007, Journal of viral hepatitis.
[7] Mark Wright,et al. Estimated progression rates in three United Kingdom hepatitis C cohorts differed according to method of recruitment. , 2006, Journal of clinical epidemiology.
[8] N. Andrews,et al. Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure , 2005, Epidemiology and Infection.
[9] A. Zanetti,et al. Long‐term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth , 2004, Hepatology.
[10] M. Yuen,et al. Viral hepatitis C , 2003, The Lancet.
[11] K. Ishak,et al. Long‐term mortality and morbidity of transfusion‐associated non‐A, non‐B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study , 2001, Hepatology.
[12] C. Sabin,et al. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985 , 2000, Gut.
[13] E. Kenny‐Walsh. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. , 1999, The New England journal of medicine.
[14] J. Ludwig,et al. The long‐term pathological evolution of chronic hepatitis C , 1996, Hepatology.
[15] M. Tong,et al. Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.
[16] S. Gordon,et al. The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. Intravenous drug use , 1993, Hepatology.
[17] R. Purcell,et al. Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.